Market Overview

Sanofi Buys OTC Antacid Rolaids from J&J's McNeil-PPC

Share:
Related SNY
Benzinga's Option Alert Recap From March 28
Regeneron's Dupixent Passes The FDA Muster; Baird Sees Strong Lauch
Related JNJ
Here's Every Major Corporation That's Pulled Ads From YouTube
Watch These 5 Huge Put Purchases In Monday Trade
Dow Upends Losing Streak: Amazon, Apple Do Heavy Lifting (Investor's Business Daily)

Sanofi (NYSE : SNY) today announced that its US Consumer Healthcare Division, Chattem, Inc., completed the acquisition of the worldwide rights to the Rolaids^® brand from McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Posted-In: News M&A

 

Related Articles (JNJ + SNY)

View Comments and Join the Discussion!